From: Drug-related factors affecting medication adherence among Egyptian asthma patients
Variables | Good | Intermediate | Poor | Total | P value |
---|---|---|---|---|---|
Age/year | 43.82 ± 13.501 | 42.61 ± 13.05 | 37.56 ± 15.84 | 41.86 ± 14.06 | 0.082 |
Gender | 0.295 | ||||
Males | 12 (26.7%) | 9 (23.7%) | 11 (40.7%) | 32 (29.1%) | |
Females | 33 (73.3%) | 29 (76.3%) | 16 (59.3%) | 78 (70.9%) | |
Residence | 0.742 | ||||
Rural | 19 (42.2%) | 13 (34.2%) | 11 (40.7%) | 43 (39.1%) | |
Urban | 26 (57.8%) | 25 (65.8%) | 16 (59.3%) | 67 (60.9%) | |
Educational level | 0.563 | ||||
Illiterate | 24 (53.3%) | 20 (52.6%) | 11 (40.7%) | 55 (50%) | |
Primary | 6 (13.3%) | 8 (21.1%) | 4 (14.8%) | 18 (16.4%) | |
Secondary | 14 (31.1%) | 9 (23.7%) | 9 (33.3%) | 32 (29.1%) | |
Graduate | 0 (0.0%) | 1 (2.6%) | 1 (3.7%) | 2 (1.8%) | |
Postgraduate | 1 (2.2%) | 0 (0.0%) | 2 (7.4%) | 3 (2.7%) | |
Socioeconomic | 0.05 | ||||
Low | 0 (0.0%) | 2 (5.3%) | 2 (7.4%) | 4 (3.6%) | |
Middle | 45 (100%) | 36 (94.7%) | 23 (85.2%) | 104 (94.5%) | |
High | 0 (0.0%) | 0 (0.0%) | 2 (7.4%) | 2 (1.8%) | |
Smoking status | 0.289 | ||||
Non | 42 (93.3%) | 34 (89.5%) | 21 (77.8%) | 97 (88.2%) | |
Ex-smoker | 3 (6.7%) | 3 (7.9%) | 3 (11.1%) | 9 (8.2%) | |
Stop smoking | 0 (0.0%) | 1 (2.6%) | 2 (7.4%) | 3 (2.7%) | |
Current smoker | 0 (0.0%) | 0 (0.0%) | 1 (3.7%) | 1 (0.9%) | |
Smoking index | 0.797 | ||||
Mild | 1 (50%) | 0 (0.0%) | 2(40%) | 3 (37.5%) | |
Moderate | 0 (0.0%) | 0 (0.0%) | 1 (20%) | 1 (12.5%) | |
Heavy | 1 (50%) | 1 (100%) | 2 (40%) | 4 (50%) | |
Degree of asthma | 0.082 | ||||
Intermittent | 32 (45.7%) | 8 (21.1%) | 21 (36.2%) | 61 (36.7%) | |
Mild persistent | 4 (5.7%) | 9 (23.7%) | 10 (17.2%) | 23 (13.9%) | |
Moderate persistent | 25 (35.7%) | 15 (39.5%) | 21 (36.2%) | 61 (36.7%) | |
Severe persistent | 9 (12.9%) | 6 (15.8%) | 6 (10.3%) | 21 (12.7%) | |
Duration of disease | 14.49 ± 9.36 | 11.74 ± 8.45 | 10.83 ± 10.32 | 12.64 ± 10 | 0.097 |
No. of emergency visit/last year | 0.231 | ||||
1 visits | 35 (77.8%) | 34 (89.5%) | 19 (70.4%) | 88 (80%) | |
2-4 visits | 7 (15.6%) | 4 (10.5%) | 7 (25.9%) | 18 (16.4%) | |
> 4 visits | 3 (6.7%) | 0 (0.0%) | 1 (3.7%) | 4 (3.6%) | |
No. comorbidities | 27 (32.53%) | 31 (37.34%) | 25(30.13%) | 0.153 | |
1 comorbidities | 11 (40.74%) | 9 (33.33%) | 7 (25.93%) | 83 (75.45%) | |
≥ 2 comorbidities | 27 (24.55%) |